Maraviroc (MVC) increases CD4+ and CD8+ cells: long-term data from the MVC clinical development program
暂无分享,去创建一个
M. Battegay | A. Lazzarin | H. Valdez | R. Burnside | G. Mukwaya | D. Chapman | S. Portsmouth | S. Valluri | J. McCracken | J. Sierra‐Madero | J. Heera